These engineered NSCLC cells exhibited a substantial upregulation of TIMM23 mRNA expression (Fig. 9J) without affecting the control TIMM17A mRNA levels (Fig. 9K). This evidence concerns the gene TIMM23 and non-small cell lung carcinoma.